Searched for
BIOPHARMA
Our central mission must be patient-centric innovation: JP NaddaJ P Nadda urges industry to take discoveries ‘from bench to bedside’ as the FICCI–Lilly Bharat Life Sciences Award backs its inaugural coho...- Indian companies must invest in R&D, move from generics to innovation-led industry: Pharma leadersIndian pharmaceutical leaders emphasize the need for investment in innovation to transition from generics to innovative products. They high...
- The debate is settling, the business is moving. Time to look at a larger set? 9 sugar-ethanol ecosystem stocks for the watchlistA new fuel programme is not an easy thing to implement. And it sparks intense debate. Ethanol, for instance, has taken over two decades to ...
- Stocks in news: Infosys, HDFC Bank, Jio Financial, IRFC, NCC and Blue DartIndian equity benchmarks experienced a decline over two sessions due to profit booking and rising oil prices. The Nifty 50 index closed dow...
- Where Does China Fit in Your Company’s Innovation Strategy?For decades, multinationals treated China primarily as either a vast growth market or a rising competitive threat. But as growth slows, com...
- Why is Summit Therapeutics share price up today by 22%?Summit Therapeutics share price is up today by 22% after biopharma firm announced AstraZeneca would invest $2 billion in it. British drugma...
- Ichor Biologics seeks $80-100 million PE funding for minority stake saleIchor Biologics is seeking eighty to one hundred million dollars from private equity investors. The Hyderabad-based company operates in the...
- A Virginia dairy takes 105,000 tons of discarded food and drink each year instead of sending it to waste; it becomes renewable gasA Virginia dairy farm is pioneering a method to convert food waste and cow manure into renewable energy. By producing renewable natural gas...
- Agonisingly slow clinical trial is stopping Indian pharma become global innovator from supplierIndia's regulatory hurdles slow down early-stage drug trials significantly. This complexity causes Indian companies to conduct crucial firs...
- Biocon shares rise 3% after Rs 638-crore block deal; Active Pine likely sellerBiocon shares rose after a block deal involving around 1.65 crore shares. Investor Active Pine was reportedly looking to sell up to 1.66 cr...
- Karnataka plans $400 billion Bengaluru region economy by 2037Karnataka plans to expand Bengaluru's economy to $400 billion by 2037. The master plan aims to create millions of new jobs and boost key se...
- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsGiven the possibility of hostilities resuming in the Gulf region, focus on risk management in the market. Why? Because fresh hostilities wi...
- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsHere’s one thing to watch for in the next few weeks: How does the street treat disappointments in the mid-cap segment? If the reaction is l...
- Biocon shares rise 2% after USFDA approval for Yesintek single-dose prefilled autoinjectorBiocon shares rose after its US subsidiary received supplemental FDA approval for Yesintek single-dose prefilled autoinjectors in two stren...
- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsWhat is volatility? There is, of course, a mathematical definition. Then there is the human definition, which is how investors feel it. In ...
- Independence Day 2026: India, which once couldn't make smallpox vaccine, has now crossed a pharma milestone the world can't ignore2026 Independence Day: India's pharmaceutical industry marks a historic milestone with a new drug approval. This achievement reflects decad...
- Piramal Pharma to focus on policy, not Trump tariff tweets: Nandini PiramalPiramal Pharma will focus on policy actions amid tariff concerns. Its global manufacturing network offers a significant advantage. The comp...
- Budget 2026: Sitharaman launches 'Biopharma Shakti' with a Rs 10,000-crore bet to heal India, power manufacturingUnion Budget 2026: With the announcement of the 'Biopharma Shakti' initiative, India is gearing up to take the world stage in biopharmaceut...
- Budget 2026: Sitharaman proposes Rs 10,000-crore Biopharma Shakti scheme to boost biopharma manufacturingThe proposed fund aims to position India as a global biopharma manufacturing hub
- Telangana plans country’s first biopharma hubTelangana government proposes to set up India’s first Biopharma-Hub to provide support to the biopharma research and development activities.
Load More
